nach oben

Journal of Natural Medicines

Erschienen in:

01.01.2019 | Note

Geraniin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) via activating β-catenin: a comparative study between BMSCs from normal and osteoporotic rats

verfasst von: Jiao Mo, Renhua Yang, Fan Li, Bo He, Xiaochao Zhang, Yuqin Zhao, Zhiqiang Shen, Peng Chen

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Abnormal osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) has been correlated with the pathogenesis of osteoporosis. Geraniin, a polyphenolic compound isolated from Phyllanthus amarus, is effective in preventing osteoporosis, but the mechanisms of action of geraniin and the impact of osteoporotic condition on drug action are not known. In this study we compared the proliferation and osteoblastic differentiation potential of BMSCs from normal rats with that from osteoporotic rats, and examined the responses of both BMSCs to geraniin in parallel. BMSCs of rats subjected to ovariectomy or sham operation were isolated and treated with geraniin. Cell proliferation was measured by CCK-8 assay. Osteoblastic differentiation was quantified by Alizarin Red S staining and alkaline phosphatase assay. Nuclear translocation of β-catenin was monitored by immunofluorescent staining. Expression of β-catenin was determined by Western blot and quantitative real-time polymerase chain reaction. Results showed that the proliferation and osteoblast formation of osteoporotic BMSCs decreased in comparison to that of normal BMSCs. Geraniin enhanced proliferation and osteoblastic differentiation of both BMSCs, but the responses of osteoporotic BMSCs to geraniin were less than those of normal BMSCs. Expression and nuclear accumulation of β-catenin in osteoporotic BMSCs were found to be diminished. Geraniin increased nuclear translocation and expression of β-catenin in both BMSCs. This study associated the osteogenic effect of geraniin to activation of Wnt/β-catenin signaling, and provided rationale for pharmacological investigation of geraniin in osteoporosis prevention and treatment.

Das S, Crockett JC (2013) Osteoporosis—a current view of pharmacological prevention and treatment. Drug Des Dev Ther 7:435–448. https://doi.org/10.2147/DDDT.S31504 CrossRef

Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, Lanyon LE (2007) Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 282:20715–20727. https://doi.org/10.1074/jbc.M703224200 CrossRef

Bhukhai K, Suksen K, Bhummaphan N, Janjorn K, Thongon N, Tantikanlayaporn D, Piyachaturawat P, Suksamrarn A, Chairoungdua A (2012) A phytoestrogen diarylheptanoid mediates estrogen receptor/Akt/glycogen synthase kinase 3beta protein-dependent activation of the Wnt/beta-catenin signaling pathway. J Biol Chem 287:36168–36178. https://doi.org/10.1074/jbc.M112.344747 CrossRefPubMedPubMedCentral

Shoback D (2007) Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab 92:747–753. https://doi.org/10.1210/jc.2007-0042 CrossRefPubMed

Saeed H, Ahsan M, Saleem Z, Iqtedar M, Islam M, Danish Z, Khan AM (2016) Mesenchymal stem cells (MSCs) as skeletal therapeutics—an update. J Biomed Sci 23:41. https://doi.org/10.1186/s12929-016-0254-3 CrossRefPubMedPubMedCentral

Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2(1):35–43. https://doi.org/10.1038/ncprheum0070 CrossRefPubMed

Hoeppner LH, Secreto FJ, Westendorf JJ (2009) Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Target 13:485–496. https://doi.org/10.1517/14728220902841961 CrossRef

Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukar Gene Expr 19:109–124CrossRef

Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492:1–18. https://doi.org/10.1016/j.gene.2011.10.044 CrossRefPubMed

10.

Patel JR, Tripathi P, Sharma V, Chauhan NS, Dixit VK (2011) Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol 138:286–313. https://doi.org/10.1016/j.jep.2011.09.040 CrossRefPubMed

11.

Lu Y, He B, Zhang X, Yang R, Li S, Song B, Zhang Y, Yun Y, Yan H, Chen P, Shen Z (2015) Osteoprotective effect of geraniin against ovariectomy-induced bone loss in rats. Bioorg Med Chem Lett 25:673–679. https://doi.org/10.1016/j.bmcl.2014.11.081 CrossRefPubMed

12.

He B, Hu M, Li SD, Yang XT, Lu YQ, Liu JX, Chen P, Shen ZQ (2013) Effects of geraniin on osteoclastic bone resorption and matrix metalloproteinase-9 expression. Bioorg Med Chem Lett 23:630–634. https://doi.org/10.1016/j.bmcl.2012.12.005 CrossRefPubMed

13.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8:315–317. https://doi.org/10.1080/14653240600855905 CrossRefPubMed

14.

Li F, Wang X, Niyibizi C (2010) Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 47:546–555. https://doi.org/10.1016/j.bone.2010.05.040 CrossRefPubMedPubMedCentral

15.

Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575. https://doi.org/10.1016/j.joms.2005.07.010 CrossRefPubMed

16.

Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG (2012) Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg Br 94:385–390. https://doi.org/10.1302/0301-620X.94B3.27999 CrossRefPubMed

17.

Watanabe A, Yoneyama S, Nakajima M, Sato N, Takao-Kawabata R, Isogai Y, Sakurai-Tanikawa A, Higuchi K, Shimoi A, Yamatoya H, Yoshida K, Kohira T (2012) Osteosarcoma in Sprague–Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34)). J Toxicol Sci 37:617–629CrossRef

18.

Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D (2012) The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res 27:2429–2437. https://doi.org/10.1002/jbmr.1768 CrossRefPubMedPubMedCentral

19.

Fan JZ, Yang L, Meng GL, Lin YS, Wei BY, Fan J, Hu HM, Liu YW, Chen S, Zhang JK, He QZ, Luo ZJ, Liu J (2014) Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway. Mol Cell Biochem 392:85–93. https://doi.org/10.1007/s11010-014-2021-7 CrossRefPubMedPubMedCentral

20.

Rodriguez JP, Garat S, Gajardo H, Pino AM, Seitz G (1999) Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. Mol Cell Biochem 75:414–423CrossRef

21.

Wang Z, Goh J, De Das S, Ge Z, Ouyang H, Chong JS, Low SL, Lee EH (2006) Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 12:1753–1761. https://doi.org/10.1089/ten.2006.12.1753 CrossRef

22.

Pino AM, Rosen CJ, Rodriguez JP (2012) In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 45:279–287. https://doi.org/10.4067/S0716-97602012000300009 CrossRef

23.

Wang D, Wang Y, Xu S, Wang F, Wang B, Han K, Sun D, Li L (2016) Epigallocatechin-3-gallate protects against hydrogen peroxide-induced inhibition of osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Stem Cells Int 2016:7532798. https://doi.org/10.1155/2016/7532798 CrossRefPubMedPubMedCentral

24.

Gao B, Huang Q, Lin YS, Wei BY, Guo YS, Sun Z, Wang L, Fan J, Zhang HY, Han YH, Li XJ, Shi J, Liu J, Yang L, Luo ZJ (2014) Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway. PLoS One 9:e99137. https://doi.org/10.1371/journal.pone.0099137 CrossRefPubMedPubMedCentral

25.

Jin C, Zhang P, Zhang M, Zhang X, Lv L, Liu H, Liu Y, Zhou Y (2016) Inhibition of SLC7A11 by sulfasalazine enhances osteogenic differentiation of mesenchymal stem cells by modulating BMP2/4 expression and suppresses bone loss in ovariectomized mice. J Bone Miner Res 32:508–521. https://doi.org/10.1002/jbmr.3009 CrossRefPubMed

26.

Wang C, Wang J, Li J, Hu G, Shan S, Li Q, Zhang X (2016) KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis. Cell Death Dis 7:e2335. https://doi.org/10.1038/cddis.2016.238 CrossRefPubMedPubMedCentral

27.

Li K, Zhang X, He B, Yang R, Zhang Y, Shen Z, Chen P, Du W (2018) Geraniin promotes osteoblast proliferation and differentiation via the activation of Wnt/beta-catenin pathway. Biomed Pharmacother 99:319–324. https://doi.org/10.1016/j.biopha.2018.01.040 CrossRefPubMed

28.

Baron R, Rawadi G (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635–2643. https://doi.org/10.1210/en.2007-0270 CrossRefPubMed

29.

Kobayashi Y, Uehara S, Udagawa N, Takahashi N (2016) Regulation of bone metabolism by Wnt signals. J Biochem 159:387–392. https://doi.org/10.1093/jb/mvv124 CrossRefPubMed

30.

Jing H, Liao L, An Y, Su X, Liu S, Shuai Y, Zhang X, Jin Y (2016) Suppression of EZH2 prevents the shift of osteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis. Mol Ther 24:217–229. https://doi.org/10.1038/mt.2015.152 CrossRefPubMed

31.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GCM, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard M-J, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523. https://doi.org/10.1016/S0092-8674(01)00571-2 CrossRefPubMed

32.

Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao S-C, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high–bone-mass trait. Am J Hum Genet 70:11–19CrossRef

33.

Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO (2004) Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 19:2033–2040. https://doi.org/10.1359/JBMR.040907 CrossRefPubMed

34.

Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407:535–538. https://doi.org/10.1038/35035124 CrossRefPubMed

35.

Yu H-MI, Jerchow B, Sheu T-J, Liu B, Costantini F, Puzas JE, Birchmeier W, Hsu W (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132:1995CrossRef

36.

Yan Y, Tang D, Chen M, Huang J, Xie R, Jonason JH, Tan X, Hou W, Reynolds D, Hsu W, Harris SE, Puzas JE, Awad H, Keefe RJ, Boyce BF, Chen D (2009) Axin2 controls bone remodeling through the β-catenin–BMP signaling pathway in adult mice. J Cell Sci 122:3566CrossRef

37.

Futami I, Ishijima M, Kaneko H, Tsuji K, Ichikawa-Tomikawa N, Sadatsuki R, Muneta T, Arikawa-Hirasawa E, Sekiya I, Kaneko K (2012) Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS One 7:e45517. https://doi.org/10.1371/journal.pone.0045517 CrossRefPubMedPubMedCentral

38.

Li F, Wang X, Niyibizi C (2007) Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 25:3183–3193. https://doi.org/10.1634/stemcells.2007-0466 CrossRefPubMed

39.

Wang C, Jin H, Wang N, Fan S, Wang Y, Zhang Y, Wei L, Tao X, Gu D, Zhao F, Fang J, Yao M, Qin W (2016) Gas6/Axl Axis contributes to chemoresistance and metastasis in breast cancer through Akt/GSK-3beta/beta-catenin signaling. Theranostics 6:1205–1219. https://doi.org/10.7150/thno.15083 CrossRefPubMedPubMedCentral

Titel: Geraniin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) via activating β-catenin: a comparative study between BMSCs from normal and osteoporotic rats
verfasst von: Jiao Mo
Renhua Yang
Fan Li
Bo He
Xiaochao Zhang
Yuqin Zhao
Zhiqiang Shen
Peng Chen
Publikationsdatum: 01.01.2019
Verlag: Springer Singapore
Erschienen in: Journal of Natural Medicines / Ausgabe 1/2019
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-018-1242-6

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Geraniin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) via activating β-catenin: a comparative study between BMSCs from normal and osteoporotic rats

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Oenothein B, dimeric hydrolysable tannin inhibiting HCV invasion from Oenothera erythrosepala

New depsidone and dichromone from the stems of Garcinia paucinervis with antiproliferative activity

A review of the ethnopharmacology, phytochemistry, and pharmacology of Changium smyrnioides Wolff

Two new oleanane derivatives from the fruits of Leonurus japonicus and their cytotoxic activities

Cholestane glycosides from Ornithogalum saundersiae bulbs and the induction of apoptosis in HL-60 cells by OSW-1 through a mitochondrial-independent signaling pathway

Screening for natural medicines effective for the treatment of osteoporosis